Details for New Drug Application (NDA): 050202
✉ Email this page to a colleague
NDA 050202 describes CHLOROMYCETIN HYDROCORTISONE, which is a drug marketed by Parkedale and is included in one NDA. Additional details are available on the CHLOROMYCETIN HYDROCORTISONE profile page.
The generic ingredient in CHLOROMYCETIN HYDROCORTISONE is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.
The generic ingredient in CHLOROMYCETIN HYDROCORTISONE is chloramphenicol; hydrocortisone acetate. There are fourteen drug master file entries for this compound. Additional details are available on the chloramphenicol; hydrocortisone acetate profile page.
Summary for 050202
| Tradename: | CHLOROMYCETIN HYDROCORTISONE |
| Applicant: | Parkedale |
| Ingredient: | chloramphenicol; hydrocortisone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;OPHTHALMIC | Strength | 12.5MG/VIAL;25MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
